Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Jared S. Katzeff, Fiona Bright, Katherine Phan, et al.
Brain (2022) Vol. 145, Iss. 5, pp. 1598-1609
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes
Hubert Grel, Damian Woźnica, Katarzyna Ratajczak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13033-13033
Open Access | Times Cited: 38
Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study
Marta Truffi, Maria Garofalo, Alessandra Ricciardi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Frontotemporal dementia. How to deal with its diagnostic complexity?
Annibale Antonioni, Emanuela Maria Raho, Enrico Granieri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access | Times Cited: 1
Emerging perspectives of synaptic biomarkers in ALS and FTD
Karrthik Krishnamurthy, Raj Kumar Pradhan
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 6
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.
Domizia Vecchio, Chiara Puricelli, Simona Malucchi, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 82, pp. 105412-105412
Open Access | Times Cited: 14
Enhancing ALS disease management: exploring integrated user value through online communities evidence
Jan Hruška, Pavel Bachmann, Samuel Amponsah Odei
Frontiers in Neurology (2025) Vol. 15
Open Access
Biomarkers in frontotemporal dementia: Current landscape and future directions
Abbott Gifford, Nathan Praschan, Amy Newhouse, et al.
Biomarkers in Neuropsychiatry (2023) Vol. 8, pp. 100065-100065
Open Access | Times Cited: 12
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies
Pei‐Chuan Ho, Tsung‐Chi Hsieh, Kuen‐Jer Tsai
Ageing Research Reviews (2024) Vol. 100, pp. 102441-102441
Open Access | Times Cited: 4
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Rawiah S. Alshehri, Ahmad R. Abuzinadah, Moafaq S. Alrawaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10900-10900
Open Access | Times Cited: 4
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Fabiola De Marchi, Giacomo Tondo, Lucia Corrado, et al.
Genes (2023) Vol. 14, Iss. 8, pp. 1658-1658
Open Access | Times Cited: 10
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds
Guangcheng Zhong, Xinyue Wang, Jiaqi Li, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1650-1671
Open Access | Times Cited: 9
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Mary‐Louise Rogers, David Schultz, Vassilios Karnaros, et al.
Brain Communications (2023) Vol. 5, Iss. 6
Open Access | Times Cited: 8
Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis
Han Wang, Yi-Ti Liu, Yanling Ren, et al.
Journal of Neuroimmunology (2024) Vol. 388, pp. 578290-578290
Closed Access | Times Cited: 2
Differential diagnosis of frontotemporal dementia subtypes with explainable deep learning on structural MRI
Da Ma, Jane Stocks, Howard J. Rosen, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Poly-GR repeats associated with ALS/FTD gene C9ORF72 impair translation elongation and induce a ribotoxic stress response in neurons
Daoyuan Dong, Zhe Zhang, Yini Li, et al.
Science Signaling (2024) Vol. 17, Iss. 848
Open Access | Times Cited: 2
Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review
Ioannis Liampas, Panagiota Kyriakoulopoulou, Vasiliki Karakoida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11838-11838
Open Access | Times Cited: 2
Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
Katherine Phan, Ying He, Surabhi Bhatia, et al.
Brain Communications (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Interrogating the Metabolomic Profile of Amyotrophic Lateral Sclerosis in the Post-Mortem Human Brain by Infrared Matrix-Assisted Laser Desorption Electrospray Ionization (IR-MALDESI) Mass Spectrometry Imaging (MSI)
Alexandria L. Sohn, Lingyan Ping, Jonathan D. Glass, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1096-1096
Open Access | Times Cited: 9
Protein Biomarkers Shared by Multiple Neurodegenerative Diseases Are Calmodulin-Binding Proteins Offering Novel and Potentially Universal Therapeutic Targets
Danton H. O’Day
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7045-7045
Open Access | Times Cited: 5
The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials
Jay L.P. Fieldhouse, Dirk N. van Paassen, Marie‐Paule E. van Engelen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases
Danton H. O’Day
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13424-13424
Open Access | Times Cited: 1
La sclérose latérale amyotrophique : une maladie neurodégénérative emblématique
Fausto Viader
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 3, pp. 272-286
Open Access | Times Cited: 2
Characteristics, Recombination Methods, and Applications Progresses of Split-Cas9 System
Zhixi Liu, Lu Huang, Han Deng, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 13-14, pp. 594-604
Closed Access | Times Cited: 2
Spatial and Temporal Relationships Between Atrophy and Hypometabolism in Behavioral-Variant Frontotemporal Dementia
Jane Stocks, Erin Gibson, Karteek Popuri, et al.
Alzheimer Disease & Associated Disorders (2024)
Closed Access
Page 1 - Next Page

Scroll to top